Stockreport

QIAGEN takes legal action to defend QuantiFERON intellectual property and protect innovations in latent tuberculosis testing

Qiagen N.V. Common Shares  (QGEN) 
Last qiagen n.v. common shares earnings: 2/4 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: corporate.qiagen.com/investor-relations
PDF QIAGEN files lawsuit against bioMérieux with German Unified Patent Court to protect key innovations in its QuantiFERON technologyQuantiFERON-TB Gold Plus plays a critica [Read more]